Viewing Study NCT06943950


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2025-12-27 @ 12:50 PM
Study NCT ID: NCT06943950
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-30
First Post: 2025-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-06-01
Start Date Type: ESTIMATED
Primary Completion Date: 2027-04-28
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2025-04-17
First Submit QC Date: None
Study First Post Date: 2025-04-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-27
Last Update Post Date: 2025-04-30
Last Update Post Date Type: ACTUAL